Acrivon Competitors and Similar CompaniesClear all
Acrivon's competitors and similar companies include Iksuda Therapeutics.
 Acrivon Acrivon (also known as Acrivon Therapeutics) is a clinical-stage oncology company that leverages a precision medicine platform called Acrivon Predictive Precision Proteomics (AP3) for the development of a drug pipeline. |  Iksuda Therapeutics Iksuda is a biotechnology company that focuses on developing antibody-based therapies for the treatment of cancer. | |
Founding Date | Founding Date 2018 | Founding Date 2007 |
Type | Type Public | Type Private |
Tags | ||
Locations | Locations Watertown, US HQ Lund, SE | Locations Newcastle upon Tyne, GB HQ Newton, US |
Employees | Employees 415% increase | Employees 43 |
For sources of this data, please see the company profile
View Company Profiles
Iksuda Therapeutics
HQ
Newcastle upon Tyne, GB
Employees
43
Iksuda is a biotechnology company that focuses on developing antibody-based therapies for the treatment of cancer.
View company